Letters, Testimony & Filings Public Citizen Comments on Section 232 Investigation on Pharmaceuticals May 7, 2025
Commentary Trump Administration’s New Big Pharma Hit List Raises Concerns About “Reciprocal Tariffs” Talks April 30, 2025
Press Releases 2025 Annual USTR Report Resurrects Corporate Wishlist, Attacking Climate, Health, and Digital Regulation April 1, 2025
Press Releases U.S. Must Play a More Active Role in Regulating Climate Finance to Protect Global South October 16, 2024
Letters, Testimony & Filings Testimony to Senate Finance, House Ways & Means: The President’s 2024 Trade Policy Agenda May 1, 2024
Press Releases Corporate Greed and Rich Countries’ Cowardice Lead WTO to Abandon Proposed Sharing of COVID Treatment Technologies January 31, 2024
Letters, Testimony & Filings Public Citizen Comments for the 2024 Special 301 Review January 31, 2024